Eligibility:
The international Galien award for pharmaceutical research is organized every second year, and is given to recently marketed drugs that have been won a national award. See below the list of the potential submissions with the country where they have been awarded.
Originating Company Trade Name Compound Country Year Abbott Humira Adalimumab USA 2007 Alexion Soliris Eculizumab USA, France 2008 Amgen Nplate Romiplostim USA 2009 Bayer - Schering Xarelto Rivaroxaban Belgium 2009 Bayer - Schering Nexavar Sorafenib France 2008 Biocodex Diacomit Stiripentol France 2008 Biogen IDEC Tysabri Natalizumab France 2009 Bristol Myers Squibb Orencia Abatacept Switzerland 2009 Celgene Revlimid Lenalidomide USA 2008 GSK Cervarix Human Papillomavirus Bivalent United Kingdom 2009 GSK Promacta Eltrombopag USA 2009 Merck Isentress Raldegravir USA, France, Italy 2008 Merck Januvia Sitagliptine USA, The Netherlands 2007 Novartis Pharmaceuticals Lucentis Ranibizumab Belgium 2008 Novartis Pharmaceuticals Xolair Omalizumab Italy 2008 Novartis Pharmaceuticals Exjade Deferasirox United Kingdom 2008 Pfizer Selzentry Maravirox USA, The Netherlands 2008 Pfizer Chantix Varenicline USA, Canada 2007 Pharmapharm Yondelis Trabectidine Spain 2009 Servier Procoralan Ivabradine France, Germany, Italy, Spain 2008 Swedish Orphan Int'l Orfadin Nitisinon Germany 2009 Wyeth Infuse RhBMP-2 USA 2008
Submissions:
A separate entry form must be completed for each drug or device entered.
Requirements:
Please submit the following information for each drug submitted:
- Therapeutic Category(s)
- Background info/need for drug/device
- History of product development
- Why product is innovative
- Pubmed references
You will be provided an upload form for each topic in order to enhance your submission file.
Technical note:
Your browser software must accept cookies in order to enter the secured area of the site.
You can usually set it up in the Security tab of the Preferences panel of your browser.
|
Not yet registered?
|
